Literature DB >> 28875248

Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al.

Karin Ribi1, Alan Coates2, Lynette Blacher3, Meredith M Regan4, Richard D Gelber5, Jürg Bernhard6.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28875248     DOI: 10.1007/s11136-017-1695-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


× No keyword cloud information.
  24 in total

1.  Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

Authors:  Jürg Bernhard; Weixiu Luo; Karin Ribi; Marco Colleoni; Harold J Burstein; Carlo Tondini; Graziella Pinotti; Simon Spazzapan; Thomas Ruhstaller; Fabio Puglisi; Lorenzo Pavesi; Vani Parmar; Meredith M Regan; Olivia Pagani; Gini F Fleming; Prudence A Francis; Karen N Price; Alan S Coates; Richard D Gelber; Aron Goldhirsch; Barbara A Walley
Journal:  Lancet Oncol       Date:  2015-06-16       Impact factor: 41.316

2.  Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.

Authors:  C Hürny; J Bernhard; A S Coates; M Castiglione-Gertsch; H F Peterson; R D Gelber; J F Forbes; C M Rudenstam; E Simoncini; D Crivellari; A Goldhirsch; H J Senn
Journal:  Lancet       Date:  1996-05-11       Impact factor: 79.321

3.  Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation.

Authors:  Diane Wild; Alyson Grove; Mona Martin; Sonya Eremenco; Sandra McElroy; Aneesa Verjee-Lorenz; Pennifer Erikson
Journal:  Value Health       Date:  2005 Mar-Apr       Impact factor: 5.725

4.  Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data.

Authors:  J Bernhard; H F Peterson; A S Coates; H Gusset; M Isley; R Hinkle; R D Gelber; M Castiglione-Gertsch; C Hürny
Journal:  Stat Med       Date:  1998 Mar 15-Apr 15       Impact factor: 2.373

5.  Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.

Authors:  J Bernhard; C Hürny; A S Coates; H F Peterson; M Castiglione-Gertsch; R D Gelber; A Goldhirsch; H J Senn; C M Rudenstam
Journal:  Ann Oncol       Date:  1997-09       Impact factor: 32.976

6.  The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).

Authors:  C Hürny; J Bernhard; M Bacchi; B van Wegberg; M Tomamichel; U Spek; A Coates; M Castiglione; A Goldhirsch; H J Senn
Journal:  Support Care Cancer       Date:  1993-07       Impact factor: 3.603

7.  Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer.

Authors:  C K Lee; M R Stockler; A S Coates; V Gebski; S J Lord; R J Simes
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

8.  Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

Authors:  Karin Ribi; Weixiu Luo; Jürg Bernhard; Prudence A Francis; Harold J Burstein; Eva Ciruelos; Meritxell Bellet; Lorenzo Pavesi; Ana Lluch; Marilena Visini; Vani Parmar; Carlo Tondini; Pierre Kerbrat; Antonia Perelló; Patrick Neven; Roberto Torres; Davide Lombardi; Fabio Puglisi; Per Karlsson; Thomas Ruhstaller; Marco Colleoni; Alan S Coates; Aron Goldhirsch; Karen N Price; Richard D Gelber; Meredith M Regan; Gini F Fleming
Journal:  J Clin Oncol       Date:  2016-03-28       Impact factor: 44.544

9.  Assessing health-related quality of life in patients with breast cancer: a systematic and standardized comparison of available instruments using the EMPRO tool.

Authors:  Stefano Maratia; Sergio Cedillo; Javier Rejas
Journal:  Qual Life Res       Date:  2016-04-05       Impact factor: 4.147

10.  Clinical relevance of single item quality of life indicators in cancer clinical trials.

Authors:  J Bernhard; M Sullivan; C Hürny; A S Coates; C M Rudenstam
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

View more
  2 in total

1.  Assessing health-related quality of life in patients with breast cancer: a reply to Ribi et al.

Authors:  Stefano Maratia; Sergio Cedillo; Javier Rejas
Journal:  Qual Life Res       Date:  2018-07-13       Impact factor: 4.147

2.  Predictors of Quality of Life in Patients with Breast Cancer.

Authors:  Fahimeh Sehhatie Shafaie; Mojgan Mirghafourvand; Jalileh Amirzehni
Journal:  Indian J Palliat Care       Date:  2019 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.